Exchange of Thailand The Board of Directors Meeting of Wattanapat Hospital Trang Public Company Limited (the “Company”) No. 3/2017, held on February 26, 2017, approving the audited consolidated financial
Company”) held on 7 November 2017, approving the reviewed consolidated financial statements for 3rd Quarter of 2017 ending on 30 September 2017, the Company and its subsidiaries would like to report factors
performance that leads to value-added contribution to the shareholders. Size of the transaction calculated by criteria for total value of the return from = 269.96*100 consolidated financial statements as of
more than 0.03% but less than 3% of book value of Net Tangible Assets (the reviewed of the consolidated financial statement as at 30 September 2017). Therefore, the company would need to disclose this
transaction shall be deemed as disposition of assets of the Company. The size of the transaction is 1.64 percent calculated based on the total assets of the Company based on the consolidated financial statement
based on a total value of consideration paid basis, calculated from the audited consolidated financial statements of the Company for the year ended 31 December 2017. In the previous 6-month period, the
consolidated financial statements as at December 31, 2017. Upon combination with other connected transactions over the past six months prior to the date on which the Board of Directors’ Meeting would resolve to
-volume transaction indicating value of more than 0.03% but less than 3% of book value of Net Tangible Asset or NTA (Consolidated Financial Statements as at 31 December 2017). As a result, the Company
of 8.96 percent of the net tangible asset value under the consolidated financial statements as at December 31, 2017. Upon combination with other connected transactions over the past six months prior to
than 0.03% but less than 3% of book value of Net Tangible Assets (Consolidated financial statements as at 31 December 2018). Therefore, the company would need to disclose this information to The Stock